Authors:
Imasawa, T
Utsunomiya, Y
Kawamura, T
Zhong, Y
Nagasawa, R
Okabe, M
Maruyama, N
Hosoya, T
Ohno, T
Citation: T. Imasawa et al., The potential of bone marrow-derived cells to differentiate to glomerular mesangial cells, J AM S NEPH, 12(7), 2001, pp. 1401-1409
Authors:
Miyata, T
de Strihou, CV
Imasawa, T
Yoshino, A
Ueda, Y
Ogura, H
Kominami, K
Onogi, H
Inagi, R
Nangaku, M
Kurokawa, K
Citation: T. Miyata et al., Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient, KIDNEY INT, 60(6), 2001, pp. 2351-2359
Authors:
Yamagishi, H
Yokoo, T
Imasawa, T
Mitarai, T
Kawamura, T
Utsunomiya, Y
Citation: H. Yamagishi et al., Genetically modified bone marrow-derived vehicle cells site specifically deliver an anti-inflammatory cytokine to inflamed interstitium of obstructive nephropathy, J IMMUNOL, 166(1), 2001, pp. 609-616
Authors:
Kuriyama, S
Tomonari, H
Abe, A
Imasawa, T
Hosoya, T
Citation: S. Kuriyama et al., Beneficial effect of combination therapy with an angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor on overt proteinuria in a patient with type 1 diabetic nephropathy, NEPHRON, 86(4), 2000, pp. 529-530
Authors:
Yokoo, T
Ohashi, T
Utsunomiya, Y
Kojima, H
Imasawa, T
Kogure, T
Hisada, Y
Okabe, M
Eto, Y
Kawamura, T
Hosoya, T
Citation: T. Yokoo et al., Prophylaxis of antibody-induced acute glomerlonephritis with genetically modified bone marrow-derived vehicle cells, HUM GENE TH, 10(16), 1999, pp. 2673-2678
Authors:
Imasawa, T
Nagasawa, R
Utsunomiya, Y
Kawamura, T
Zhong, Y
Makita, N
Muso, E
Miyawaki, S
Maruyama, N
Hosoya, T
Sakai, O
Ohno, T
Citation: T. Imasawa et al., Bone marrow transplantation attenuates murine IgA nephropathy: Role of a stem cell disorder, KIDNEY INT, 56(5), 1999, pp. 1809-1817